Portrait of Mark Haden wearing glasses and a suit with a purple tie, inside a circular frame labeled "Community Leader."

Mark Haden

Mark Haden is a major figure in the field of psychedelic medicines, with a long list of past and present activities and responsibilities in this field. Among—and beyond—these, he is the Clinical Supervisor for the Psychedelic Treatment Program at Qi Integrated Health and the Vice President of Business Development at Clearmind Medicine.

Mark served as the Executive Director for MAPS Canada for 10 years and is an Adjunct Professor at the University of British Columbia School of Population and Public Health. Mark has published numerous articles in respected Journals, has presented at conferences and training events in many countries, and was awarded the Queen’s Diamond Jubilee Medal in 2013 for drug policy reform work. Mark also has a well-deserved reputation as an exciting speaker who never fails to engage and surprise audiences. You can read his latest publishing here.

    • Canadian Journal of Public Health

    • International Journal of Drug Policy

    • Encyclopaedia of Public Health

    • Harm Reduction Journal

    • Open Medicine

    • Journal of Psychoactive Drugs

    • Journal of Studies on Alcohol and Drugs

    • Vice President of Business Development – Clearmind Medicine

    • Adjunct Professor at the University of British Columbia School of Population and Public Health.

    • Advisor – Psygen

    • Was Executive Director of MAPS Canada (Multidisciplinary Association for Psychedelic Studies) for 10 years.
      Obtained an MSW from UBC

    • Worked for the Addiction Services for 28 years in counselling and supervisory roles.

    • Has provided public education on drugs and drug policy for over 30 years.

    • Worked with the Health Officers Council of British Columbia on their position papers on the issue of a regulated market for all currently illegal drugs.

    • Has presented in conferences and training events in many countries

    • Awarded the Queen’s Diamond Jubilee Medal for drug policy reform work in 2013.